Target intelligence / Profile preview

Small nucleolar RNA SNORD29 (SNORD29)

Target
SNORD29
Molecular classification
Small nucleolar RNA (snoRNA), C/D box snoRNA, Non-coding RNA
01

Overview

Small nucleolar RNA SNORD29 (SNORD29, also known as U29) is a short non-coding RNA molecule found in the nucleolus of eukaryotic cells[2][3]. It belongs to the C/D box family of snoRNAs, characterized by conserved C (UGAUGA) and D (CUGA) sequence motifs[5]. SNORD29 functions mainly as a guide RNA, directing the site-specific 2'-O-methylation of the 28S ribosomal RNA at residue A4493 in humans[2]. These modifications contribute to the stability and functional assembly of ribosomes[6]. SNORD29 is encoded within an intron of the U22 host gene, along with other snoRNAs such as U22 and U25–U31[2]. While snoRNAs as a class have been implicated in broader regulatory functions and disease pathways, SNORD29's primary known role remains the modification of rRNA, with no current evidence of direct involvement in human disease or therapeutic targeting[2][1].

Other names
U29
02

Biological functions

Guide for site-specific 2'-O-methylation of ribosomal RNA (rRNA)Involved in the modification of other small nuclear RNAs (snRNAs)Plays a role in rRNA biogenesis and maturation
03

Disease associations

No direct evidence links SNORD29 to specific diseases, but dysregulation of snoRNAs broadly has been implicated in cancer, neurodegeneration, and other conditions. There are no reports of SNORD29 itself serving as a causal agent or biomarker in these diseases.

Beyond the preview

Go deeper on Small nucleolar RNA SNORD29 (SNORD29).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nucleolar RNA SNORD29 (SNORD29).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call